Inspirion Wealth Advisors’s Trinity Biotech TRIB Stock Holding History

Inspirion Wealth Advisors’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.92K	Hold	25,000	–	–	﹤0.01%	188
2026 Q1	$13.6K	Hold	25,000	–	–	﹤0.01%	181
2025 Q4	$19.8K	Buy	25,000 +15,000	+150%	+$14.7K	﹤0.01%	169
2025 Q3	$11K	Hold	10,000	–	–	﹤0.01%	150
2025 Q2	$6.5K	Hold	10,000	–	–	﹤0.01%	158
2025 Q1	$5.7K	Hold	10,000	–	–	﹤0.01%	158
2024 Q4	$9.45K	Hold	10,000	–	–	﹤0.01%	154
2024 Q3	$11K	Hold	10,000	–	–	﹤0.01%	153
2024 Q2	$21.3K	Buy	+10,000	New	+$19.4K	﹤0.01%	147

Other funds holding TRIB

Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

Inspirion Wealth Advisors's TRIB Position: Q2 2026 in Review

Inspirion Wealth Advisors held its Trinity Biotech (TRIB) position steady in Q2 2026 at 25,000 shares worth $8.92K. The position accounts for ﹤0.01% of the portfolio, ranked #188.

Inspirion Wealth Advisors first reported a position in TRIB in Q2 2024 and has held it in 9 quarters since. The position peaked at $21.3K in Q2 2024. 5 funds tracked by Wall St. Rank hold TRIB as of Q2 2026.

Inspirion Wealth Advisors held 25,000 shares of Trinity Biotech worth $8.92K as of Q2 2026.
Inspirion Wealth Advisors left its Trinity Biotech share count unchanged in Q2 2026.
Trinity Biotech made up ﹤0.01% of Inspirion Wealth Advisors's portfolio in Q2 2026, its #188 holding.
Inspirion Wealth Advisors first reported a position in Trinity Biotech in Q2 2024 and has held it in 9 quarters since.
Inspirion Wealth Advisors's Trinity Biotech position peaked at $21.3K in Q2 2024.
5 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2026.

Based on Inspirion Wealth Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.